Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The provision of pneumococcal polysaccharide vaccine, deliveries will be required from 1 March 2021 to 28 February 2025
Value - this information is considered by the supplier to be commercially sensitive information. The authority is not publishing the value so as not to prejudice the legitimate commercial interest of the supplier.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Merck Sharpe & Dohme (UK) Limited | - | ~£0 estimated from lot values | - |